Vytrus Biotech Past Earnings Performance
Past criteria checks 2/6
Vytrus Biotech has been growing earnings at an average annual rate of 34.5%, while the Personal Products industry saw earnings growing at 3.7% annually. Revenues have been growing at an average rate of 21.2% per year. Vytrus Biotech's return on equity is 10.3%, and it has net margins of 11.6%.
Key information
34.5%
Earnings growth rate
34.8%
EPS growth rate
| Personal Products Industry Growth | 8.7% |
| Revenue growth rate | 21.2% |
| Return on equity | 10.3% |
| Net Margin | 11.6% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Revenue & Expenses Breakdown
How Vytrus Biotech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 5 | 1 | 3 | 0 |
| 30 Sep 23 | 5 | 1 | 3 | 0 |
| 30 Jun 23 | 5 | 1 | 3 | 0 |
| 31 Mar 23 | 5 | 1 | 3 | 0 |
| 31 Dec 22 | 4 | 1 | 3 | 0 |
| 30 Sep 22 | 4 | 1 | 3 | 0 |
| 30 Jun 22 | 4 | 1 | 3 | 0 |
| 31 Mar 22 | 4 | 1 | 2 | 0 |
| 31 Dec 21 | 4 | 0 | 2 | 0 |
| 31 Dec 20 | 2 | 0 | 2 | 0 |
| 31 Dec 19 | 2 | 0 | 1 | 0 |
| 31 Dec 18 | 1 | 0 | 1 | 0 |
Quality Earnings: VYT has high quality earnings.
Growing Profit Margin: VYT's current net profit margins (11.6%) are lower than last year (13.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VYT has become profitable over the past 5 years, growing earnings by 34.5% per year.
Accelerating Growth: VYT's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: VYT had negative earnings growth (-10%) over the past year, making it difficult to compare to the Personal Products industry average (16.5%).
Return on Equity
High ROE: VYT's Return on Equity (10.3%) is considered low.